These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19006181)

  • 1. Bone inflammation and altered gene expression with type I diabetes early onset.
    Motyl KJ; Botolin S; Irwin R; Appledorn DM; Kadakia T; Amalfitano A; Schwartz RC; McCabe LR
    J Cell Physiol; 2009 Mar; 218(3):575-83. PubMed ID: 19006181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways.
    Botolin S; McCabe LR
    J Cell Biochem; 2006 Oct; 99(2):411-24. PubMed ID: 16619259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
    Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
    Coe LM; Irwin R; Lippner D; McCabe LR
    J Cell Physiol; 2011 Feb; 226(2):477-83. PubMed ID: 20677222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
    Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
    J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
    Klöting N; Follak N; Klöting I
    Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of 5-androstenediol to mice: pharmacokinetics and cytokine gene expression.
    Singh VK; Grace MB; Jacobsen KO; Chang CM; Parekh VI; Inal CE; Shafran RL; Whitnall AD; Kao TC; Jackson WE; Whitnall MH
    Exp Mol Pathol; 2008 Apr; 84(2):178-88. PubMed ID: 18262521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
    Fukaya N; Mochizuki K; Shimada M; Goda T
    Nutrition; 2009 Jun; 25(6):657-67. PubMed ID: 19216056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the pathology and mechanisms of type I diabetic bone loss.
    McCabe LR
    J Cell Biochem; 2007 Dec; 102(6):1343-57. PubMed ID: 17975793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.
    Motyl KJ; McCabe LR
    J Cell Physiol; 2009 Feb; 218(2):376-84. PubMed ID: 18932203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
    Kanth VR; Lavanya K; Srinivas J; Raju TN
    Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin attenuates tibial bone loss in rats with type 1 diabetes and periodontitis.
    Kim AR; Kim JH; Kim A; Sohn Y; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Nov; 16(1):306. PubMed ID: 30413166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
    Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
    Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
    Coe LM; Lippner D; Perez GI; McCabe LR
    J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
    Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
    J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose aspirin therapy decreases blood glucose levels but does not prevent type i diabetes-induced bone loss.
    Coe LM; Denison JD; McCabe LR
    Cell Physiol Biochem; 2011; 28(5):923-32. PubMed ID: 22178944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice.
    Wieteska-Skrzeczynska W; Grzelkowska-Kowalczyk K; Jank M; Maciejewski H
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():29-36. PubMed ID: 19609011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats.
    Kirwin SJ; Kanaly ST; Linke NA; Edelman JL
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5396-404. PubMed ID: 19474406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.